Table 3. Population Demographics.
No stroke | Ischaemic stroke | Total | Mann Whitney | |||||||
N | median | mean | N | median | mean | N | median | mean | p value | |
Ischaemic stroke | 436 | 0 | 0 | 61 | 1 | 1 | 497 | 0 | 0.12 | — |
Age (yr) | 436 | 46 | 46.4 | 61 | 51 | 51.5 | 497 | 47 | 47.0 | 0.025 |
Gender (% female) | 436 | 1 | 0.60 | 61 | 1 | 0.69 | 497 | 1 | 0.61 | 0.17 |
Smoking | 436 | 0 | 0.37 | 61 | 0 | 0.38 | 497 | 0 | 0.37 | 0.94 |
Hypertension | 434 | 0 | 0.14 | 61 | 0 | 0.21 | 495 | 0 | 0.15 | 0.15 |
Venous thromboemboli | 436 | 0 | 0.053 | 61 | 0 | 0.049 | 497 | 0 | 0.052 | 0.91 |
Diabetes mellitus | 436 | 0 | 0.011 | 61 | 0 | 0.033 | 497 | 0 | 0.014 | 0.19 |
Atrial fibrillation or arrythmia | 436 | 0 | 0.014 | 61 | 0 | 0.016 | 497 | 0 | 0.014 | 0.87 |
Hypercholesterolemia | 435 | 0 | 0.016 | 61 | 0 | 0.016 | 496 | 0 | 0.016 | 0.97 |
Ischaemic heart disease | 436 | 0 | 0.0046 | 61 | 0 | 0.049 | 497 | 0 | 0.01 | 0.0011 |
Myocardial or valvular disease | 436 | 0 | 0.0092 | 61 | 0 | 0 | 497 | 0 | 0.008 | 0.45 |
High output cardiac failure | 436 | 0 | 0.0046 | 61 | 0 | 0 | 497 | 0 | 0.004 | 0.6 |
Brain abscess | 436 | 0 | 0.096 | 61 | 0 | 0.098 | 497 | 0 | 0.10 | 0.96 |
Migraines | 435 | 0 | 0.35 | 61 | 0 | 0.33 | 496 | 0 | 0.35 | 0.74 |
Ever transfused (%) | 430 | 0 | 0.081 | 57 | 0 | 0.12 | 487 | 0 | 0.086 | 0.3 |
On iron treatment (oral) | 431 | 0 | 0.27 | 58 | 0 | 0.36 | 489 | 0 | 0.28 | 0.14 |
Ever used intravenous iron | 425 | 0 | 0.033 | 57 | 0 | 0.053 | 482 | 0 | 0.035 | 0.45 |
Ever used tranexamic acid | 425 | 0 | 0.028 | 57 | 0 | 0.035 | 482 | 0 | 0.029 | 0.77 |
Ever used hormones | 423 | 0 | 0.10 | 57 | 0 | 0.16 | 480 | 0 | 0.11 | 0.22 |
Oxygen saturation (SaO2, %) | 414 | 95 | 92.9 | 57 | 94 | 91.8 | 471 | 94.8 | 92.7 | 0.28 |
Hemoglobin (g/dl) | 404 | 14.2 | 15.4 | 60 | 13.8 | 17.5 | 464 | 14.1 | 15.7 | 0.25 |
Platelets (x109/dl) | 405 | 267 | 275.5 | 60 | 272.5 | 284.8 | 465 | 268 | 276.7 | 0.57 |
Serum iron (µmol/L) | 364 | 12 | 13.7 | 55 | 9 | 10.7 | 419 | 12 | 13.3 | 0.025 |
Serum transferrin saturation index, TfSI(%) | 364 | 20 | 21.7 | 56 | 15 | 18.4 | 420 | 19 | 21.2 | 0.094 |
Ferritin (µg/L) | 214 | 29.5 | 49.5 | 28 | 34.5 | 49.8 | 242 | 30 | 49.6 | 0.55 |
C-reactive protein, CRP (iu/ml) | 275 | 2 | 3.49 | 35 | 2 | 7.25 | 310 | 2 | 3.91 | 0.59 |
Prothrombin time, PT (s) | 385 | 10.7 | 10.9 | 54 | 10.5 | 11.2 | 439 | 10.7 | 11.0 | 0.08 |
Activated partial thromboplastin time, APTT (s) | 381 | 26 | 26.1 | 54 | 25.65 | 25.8 | 435 | 26 | 26.1 | 0.27 |
Thrombin time, TT (s) | 369 | 14.6 | 14.6 | 52 | 15 | 15.1 | 421 | 15 | 14.7 | 0.07 |
Fibrinogen (g/L) | 381 | 3.03 | 3.11 | 58 | 3.34 | 3.48 | 439 | 3.07 | 3.16 | 0.013 |
Factor VIII:Ag, FVIII (iu/ml) | 240 | 1.50 | 1.63 | 40 | 1.73 | 1.87 | 280 | 1.52 | 1.66 | 0.07 |
Von Willebrand Factor, VWF (iu/ml) | 177 | 1.01 | 1.25 | 25 | 1.1 | 3.00 | 202 | 1.025 | 1.47 | 0.36 |
Pulmonary artery pressure (systolic), PAP, mmHg | 217 | 23 | 24.1 | 45 | 23 | 24.1 | 262 | 23 | 24.1 | 0.69 |
Pulmonary artery pressure (diastolic), PAP, mmHg | 217 | 8 | 8.2 | 45 | 7 | 7.82 | 262 | 7 | 8.16 | 0.63 |
Pulmonary artery pressure (mean), PAP, mmHg | 214 | 14 | 14.5 | 45 | 13 | 14.0 | 259 | 14 | 14.4 | 0.51 |
Series Indicator | 436 | 2 | 1.8 | 61 | 1 | 1.63 | 497 | 2 | 1.75 | 0.13 |
Demographics of individual and combined series, with p values calculated by Mann Whitney. N, number of recordings of variable in series.